Molecule Structure

Scientific Name

Terazosin

Description of the Drug

Terazosin is an alpha-1 adrenergic antagonist used in the treatment of symptomatic benign prostatic hyperplasia and management of hypertension.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01162

Brand Name(s)

Not Available

Company Owner(s)

Apnar Pharma Lp, Teva Pharmaceuticals Usa Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Ranbaxy Laboratories Ltd, Sandoz Inc, Abbott Laboratories Pharmaceutical Products Div, Jubilant Cadista Pharmaceuticals Inc, Mylan Technologies Inc, Mylan Pharmaceuticals Inc A Viatris Co, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Adrenergic receptor alpha-1 PROTEIN FAMILY ANTAGONIST CHEMBL2094251

Unichem Links

SureChEMBL SCHEMBL6528
PharmGKB PA451612
Human Metabolome Database HMDB0015293
DrugBank DB01162
PubChem: Thomson Pharma 14805011
PubChem 5401
Mcule MCULE-4030111564
LINCS LSM-4997
Nikkaji J19.669J
BindingDB 50033111
EPA CompTox Dashboard DTXSID3023639
DrugCentral 3584
ChemicalBook CB2285511 CB9285510 CB22630517 CB73360180
Guide to Pharmacology 7302
rxnorm TERAZOSIN HYDROCHLORIDE TERAZOSIN
KEGG Ligand C07127
ChEBI 9445